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Crystal Structure of a Complex between the
Aminoglycoside Tobramycin and an Oligonucleotide
Containing the Ribosomal Decoding A Site
some at the level of the decoding aminoacyl site (A
site) on the 16S ribosomal RNA (16S rRNA) [6]. The
aminoglycoside antibiotics disrupt the bacterial mem-
brane and induce miscoding during the protein synthe-
sis [7] by binding to the A site (Figure 2A), eventually
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Universite´ Louis Pasteur provoking the death of the bacterial cell [8]. Previous
experiments have identified the footprint of the amino-15 Rue Rene´ Descartes
67084 Strasbourg Cedex glycosides on the 16S rRNA of Escherichia coli [9]. Fur-
ther experiments have shown that the same footprintFrance
could be observed on shorter RNA constructs con-
taining the A site [10–13] and that aminoglycosides bind
to the A site with micromolar affinity [12, 14–16]. KeySummary
binding features have been observed by NMR with a 27
nucleotide-long RNA fragment [13, 17–19] and, moreAminoglycoside antibiotics target the decoding amino-
recently, at 3.05 A˚ resolution by crystallography of theacyl site (A site) on the 16S ribosomal RNA and induce
bacterial ribosomal 30S subunit complexed to paromo-miscoding during translation. Here, we present the
mycin [20].crystal structure, at 2.54 A˚ resolution, of an RNA oligo-
We recently solved by X-ray crystallography the struc-nucleotide containing the A site sequence complexed
ture of a complex between an RNA construct containingto the 4,6-disubstituted 2-deoxystreptamine amino-
two bacterial A sites and two molecules of the 4,5-disub-glycoside tobramycin. The three aminosugar rings
stituted paromomycin [21]. We have now solved themaking up tobramycin interact with the deep-groove
structure of a complex containing the aminoglycosideatoms directly or via water molecules and stabilize a
tobramycin. This aminoglycoside, together with genta-fully bulged-out conformation of adenines A1492 and
micin and amikacin, is one of the most commonly usedA1493. The comparison between this structure and the
in medicine because of its low cost and reliable activityone previously solved in the presence of paromomycin
[22]. This work presents the first crystal structure of theconfirms the importance of the functional groups on
A site complexed to an aminoglycoside belonging tothe common neamine part of these two antibiotics
the 4,6-disubstituted 2-deoxystreptamine subclass. Thefor binding to RNA. Furthermore, the analysis of the
final resolution (2.54 A˚) is close enough to the resolutionpresent structure provides a molecular explanation to
of the complex containing paromomycin (2.5 A˚) to allowsome of the resistance mechanisms that have spread
a comparison of the direct and water-bridged hydrogenamong bacteria and rendered aminoglycoside antibi-
bonds involving the antibiotics and the RNA. In bothotics inefficient.
complexes, rings I and II, constituting the common core
for the 4,5- and 4,6-disubstituted 2-deoxystreptamine
Introduction aminoglycosides, bind to the A site pocket in the same
way. The different recognition modes, due to the intrin-
RNA molecules constitute attractive targets for drug sic difference in the chemical structures of the com-
design because of their complex three-dimensional ar- pound, help us to draw the chemical and stereochemical
chitectures and their essential cellular roles [1–3]. Sev- features important for specific binding to the A site. It
eral low-molecular-weight inhibitors are already known is of a particular interest to notice that direct hydrogen
to bind with high affinities to different structural RNA bonds involving ring III and aminoglycoside atoms in
motifs [4, 5]. Among these, aminoglycosides constitute one complex are replaced by contacts mediated via
a family of water-soluble weak bases that have similar water molecules in the other complex. Therefore, the
chemical structures (Figure 1). Most of them contain a number of final contacts is roughly the same, whether
2-deoxystreptamine part substituted at different posi- ring III is attached on position 5 or 6 of ring II. These
tions by aminosugar rings, which results in polycationic results provide an explanation for the close-to-micromo-
derivatives at physiological pH. Whereas substitution at lar affinity exhibited by the structurally different paromo-
position 5 of the 2-deoxystreptamine ring leads to the mycin and tobramycin antibiotics toward the A site.
4,5-disubstituted subclass containing derivatives such Moreover, the structure of the present complex provides
as neomycin and paromomycin (Figure 1A), substitution molecular explanations for the resistance toward amino-
at position 6 leads to the 4,6-disubstituted subclass glycosides that is observed in organisms having base
containing antibiotics such as kanamycin, tobramycin mutations on the A site and/or enzymes chemically mod-
(Figure 1B), and gentamicin (Figure 1C). ifying the antibiotic.
One of the main steps in protein synthesis is the recog-
nition between messenger RNA (mRNA) and the transfer Results and Discussion
RNA (tRNA) containing the aminoacid to be incorpo-
rated. In bacteria, the recognition occurs inside the ribo- Description of the Structure of the Complex
Crystals of complexes between oligoribonucleotides in-
corporating the sequence of the A site of Escherichia coli1Correspondence: e.westhof@ibmc.u-strasbg.fr
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structure are high (100–120 A˚2 ), and the density is poorly
defined for the atoms of the two bulging adenine bases.
Inside the A site pocket, the bulging conformation of
the two adenines A1492 and A1493 is stabilized by hydrogen
bonds between phosphate oxygens and exocyclic
atoms of the invariant neamine part of the aminoglyco-
sides (Figures 3A and 3B). Rings I and II, which constitute
the common neamine core for the 4,5- and 4,6-disubsti-
tuted 2-deoxystreptamine aminoglycosides (Figure 1A),
bind to the two A site pockets in a homologous fashion
(Figures 3 and 4). Ring I intercalates in the RNA helix
and thereby stacks against base G1491 and forms a
pseudo base pair with A1408 (Figures 3F and 3G). The
pseudo base pair between ring I and A1408 involves two
hydrogen bonds, one between the ring oxygen and the
atom N6 of A1408 and a second one between the donor
at position 6 on ring I (an ammonium in tobramycin and
a hydroxyl in paromomycin) and the ring nitrogen N1 of
A1408 (Figure 3F). The hydroxyl group O4 forms a direct
H bond to the anionic O2P oxygen atom of the bulging
A1493, and the ammonium N2 is at the center of a tetrahe-
dron formed by atom C2 and three water ligands (Figure
3B). The central role of the ammonium N2 is apparent
from its coordination, although the contacts made are
via water molecules. One water molecule is responsible
for both bridging N2 intramolecularly to the hydroxyl
O5 of ring II and forming a H bond to N7(G1491), and it
thus plays the same role as the hydroxyl O5″ of ring III
in paromomycin (Figure 3B). A second water molecule
forms the same bridge to O1P(A1493) as in the paromomy-
cin complex. A third water molecule forms a water bridge
to O2P(A1492) and thereby replaces the direct contacts
formed by the hydroxyl O3 to the same anionic phos-
phate oxygen in the paromomycin complex. Thus, the
bulging conformation of the two adenines A1492 and A1493
is stabilized by the same number of homologous hydro-
gen bonds among phosphate oxygens, water molecules,
and exocyclic atoms of ring I in the neamine moiety. In
ring II, the ammonium N3 makes contacts to N7(G1494),
O2P(G1494), and O1P(A1493) that are identical to those seen
in the paromomycin complex (Figures 3A–3E). The am-
monium N1 makes an identical contact to the oxygen
O4 of U1495 of the U1495oU1406 pair and a homologous con-
tact to N4(C1496) mediated by one water molecule (in-
Figure 1. Chemical Structures of the Aminoglycosides
stead of two as in the paromomycin complex) (Figures
3C and 3D). Ring II participates in two intramolecular H
and the aminoglycoside tobramycin have been solved at bonds to ring III; one involves the atoms N1 and O2″,
2.54 A˚ resolution (Table 1). Suitable crystals could be and the second involves hydroxyl O5 and the ring oxy-
obtained only with a sequence possessing two 5 dan- gen O5″ (Figure 3B).
gling uracils, instead of the 5 cytosines that were pres- The third ring, linked to position 6 of ring II in tobra-
ent in the previous structure [21]. Crystals, belonging mycin (instead of position 5 as in paromomycin), directly
to spacegroup P21, grow as long thin plates in similar contacts the Hoogsteen sites of G1405 in the G1405C1496
crystallizing solutions containing tobramycin. The RNA pair via the hydroxyl O2″ and the ammonium N3″ (Figure
fragment consists of a double helix incorporating the A 3C), as already observed by probing and structural data
site sequence twice (Figure 2B). Because of packing for other compounds of the 4,6-linked subclass [11, 19].
contacts similar to those observed in the paromomycin The other two hydroxyl groups of ring III do not make
complex [21], one of the two sites (site 1) is better or- any contact to the RNA.
dered. The two bulged adenines of site 1 make hydrogen
bonds to the shallow groove of the central GC pairs
of a symmetry-related molecule. However, in site 2, the Comparison of the Paromomycin
and Tobramycin Complexestwo adenines are almost perpendicular to the facing
GC and CG pairs at the end of a symmetrical com- Both paromomycin and tobramycin bind to RNA con-
structs containing the A site with dissociation constantsplex. The B factors observed in the latter region of the
Crystal Structure of the A Site Complexed to Tobramycin
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Figure 2. Secondary and Tertiary Structures of the Crystallized RNA
(A) Secondary structure of the A site of the Escherichia coli 16S ribosomal RNA. The standard E. coli numbering is specified.
(B) Secondary structure of the crystallized RNA helix. The 5-dangling UU not observed in the density maps are shaded. The 3D structure of
the crystallized complex is shown. The two tobramycin molecules (cyan) and the bulged adenines (gray) are in bold, with the 1.3 3Fo  2Fc
electron density map shown in orange for the tobramycin molecules and in green and magenta for the adenines corresponding respectively
to A1492 and A1493. The 76 water molecules are shown as red spheres.
of approximately 1.5 M [16]. As listed in Table 2, the pected, the ammonium and hydroxyl groups (Table 2).
The roles of the ring oxygen atoms are more subtlenumber of contacts in the two complexes is roughly the
same (13 direct H bonds for the tobramycin complex as because these atoms participate in specific and direct
H bonds but also in intramolecular H bonds within theopposed to 15 for the paromomycin complex, a slight
difference associated with the reduced number of hy- antibiotic molecules. On the other hand, rather than
making any hydrogen bond to the RNA, the ether oxygendroxyl groups). The main binding ligands are, as ex-
Table 1. Data Collection and Structure Determination
Space group P21
Unit cell parameters (A˚) a  46.9; b  32.8; c  52.0   107.9
Wavelength (A˚) 0.933
Resolution range used for refinement (A˚)a 10–2.54 (2.64–2.54)
Number of unique reflections used in refinement 4899
Redundancy 4.8
Average I/a 19.5 (9.2)
Completeness (%)a 95.9 (98.4)
Rsym (%)ab 5.9 (13.3)
RMS deviation for bonds (A˚) 0.006
RMS deviation for angles () 1.0
Average B factor (A˚2) 61.4
Minimum B factor (A˚2) 17.8
Maximum B factor (A˚2) 119.1
R factor (%)c 21.4
Rfree (%)d 26.4
a Values for the last shell are given between parentheses.
b Rsym  |I  	I
|/	I
, where I is the measured intensity of each reflection and 	I
 is the intensity averaged from multiple observations
of symmetry-related reflections.
c R factor  ||Fo|  |Fc||/|Fo|.
d R factor calculated with 7.5% of the reflections omitted from the refinement.
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Figure 3. Close-Up of the Binding Site and Details of the Contacts
(A) Stereo view of the tobramycin in site 1. The view is toward the deep groove, with the bulged adenines on the right. Tobramycin is shown
in cyan, with functional groups colored according to the atom type. Water molecules are shown as red spheres.
(B) Tobramycin close-up showing all the hydrogen bonds involving the functional groups of tobramycin. The view has the same orientation
as in (A). Ring numbers and atom names are specified. The E. coli numbering is used for the RNA atoms, and “W” stands for a water molecule.
H bonds are shown as dashed lines, with their corresponding distances in italic.
(C–G) Atomic details of the contacts involving each base pair interacting with the tobramycin inside the A site. The color code is as in (A).
The name of each base pair is specified according to the E. coli numbering. Only a part of the tobramycin is shown at a time, with arrows
pointing to the other rings.
atoms form van der Waals contacts. This is especially pointing to N7(G1491) in the paromomycin complex is re-
placed by a water-mediated hydrogen bond involvingobserved with oxygen O1, which is in the vicinity of
O1P(A1493) and a water molecule (Figure 3A). However, O5 of ring II and two water molecules (Figure 4). Interest-
ingly, the binding mode of the neamine moitey can there-with the oxygen atoms present as hydroxyl groups in-
stead of ether groups (e.g., alternatively O6 and O5 on fore be visualized. It is probable that the two rings bind in
the same manner, with water-mediated hydrogen bondsring II of paromomycin and tobramycin), the comparison
between the crystal structures containing either a 4,5- replacing contacts involving the additional rings in the
4,5- and 4,6- subclasses. This would explain the lowerlinked or a 4,6-linked aminoglycoside shows that these
oxygen atoms are surrounded by water molecules (Fig- affinity of neamine for the A site.
We can also note from the comparison between theure 4). In the tobramycin complex, direct hydrogen
bonds are observed between atoms O2″ and N3″ of ring two aminoglycoside subclasses that the intramolecular
bonds play an important role in proper positioning ofIII and the G1405C1496 pair (Figure 4). In the paromomycin
complex, these direct contacts are replaced by water- the rings. In the paromomycin complex, ring III is main-
tained in the vicinity of ring I through two intramolecularmediated hydrogen bonds involving ring II functional
groups. In the same way, the direct hydrogen bond direct hydrogen bonds [21]. In the tobramycin complex,
Crystal Structure of the A Site Complexed to Tobramycin
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plexes is much higher than the six hydrogen bonds seen
either in the complex between neomycin and tRNAPhe
[29] or in the modeled complex between tobramycin and
polyr(I-C) [26]. It is conceivable that the latter binding
modes reflect nonspecific binding of polycations to neg-
atively charged RNA molecules [a possibility reflected
by the binding constants in the upper M range for the
neomycin/tRNAPhe complex and in the upper mM range
for the tobramycin/polyr(I-C) complex].
Comparisons with Other 4,6-Linked Aminoglycosides
Both crystal structures help understand the binding
modes of the other 4,6-linked aminoglycosides (the ka-
namycins and the gentamicins, Figures 1B and 1C). Ka-
namycin B, whose affinity for the A site is very similar
to that of tobramycin [16], differs from tobramycin by
the presence of a hydroxyl group at the C3 position;
this hydroxyl group is also present in paromomycin. As
noted above, in paromomycin, the O3 hydroxyl forms
a direct H bond with the anionic phosphate oxygen
O2P(A1492) and, in tobramycin, the contact with the
O2P(A1493) occurs via a water molecule and involves the
neighboring amino group N2 (Figure 3B). Thus, in kana-
mycin B, one expects a contact of the O3 hydroxyl as
in paromomycin. Kanamycin A possesses two hydroxyl
groups at positions 2 (replacing the N2) and 3 of ring
I. Therefore, with one amino group less than tobramycin,
it presents a 10-fold reduction in binding affinity [14],
but the contacts to the RNA should be very similar to
those formed in tobramycin (for N2) and paromomycin
(for O3).Figure 4. Superimposition of Paromomycin and Tobramycin inside
the A Site in the Crystal Structures In the gentamicin family (Figure 1C), the amino groups
(A) View of the A site as in Figure 3A. Paromomycin and tobramycin N6 of ring I and N3″ of ring III, each one forming a single
atoms are colored in orange and cyan, respectively. The superimpo- contact to the RNA, are methylated (e.g., in gentamicin
sition has been done with rings I and II in the software Lsqman C1). After the structure of gentamicin antibiotics was
[46]. The common neamine part is shown as sticks, whereas the superimposed on the crystal structure of tobramycinadditional rings, at either position O5 (for paromomycin) or O6 (for
and the missing methyl groups were modeled, it ap-tobramycin) of ring II, are shown as van der Waals spheres.
peared that the same direct hydrogen bonds involving(B) Same view as in (A), showing only the neamine common part of
the antibiotics (sticks). The water molecules replacing ring III of ammonium groups N6 and N3″ can occur between gen-
tobramycin in the paromomycin complex (upper part) and ring III tamicins and the RNA, even with gentamicin C1, which
of paromomycin in the tobramycin complex (lower part) are depicted contains one methyl group on N6 of ring I (our unpub-
as orange and cyan van der Waals spheres, respectively. lished data). The root-mean-square deviation (rmsd)
between the present X-ray structure and a single repre-
one water-bridged and two direct hydrogen bonds are sentative NMR structure of the A site complexed to the
intramolecular and seem to reinforce a conformation 4,6-linked gentamicin C1a [19] is 2.4 A˚ for all the atoms
that enables tobramycin to bind tightly to its target (Fig- of the A site. After the superimposition of the ring atoms
ure 3B). Each one of these intramolecular contacts of the neamine part (the rmsd is 0.3 A˚ for the ring atoms),
would be lost for the neamine molecule. It is noteworthy the other atoms constituting the A site present an rmsd
that the conformations and orientations of rings I and II of 3.6 A˚ between the two structures. The comparison
of tobramycin are the same in the two completely differ- shows that (1) in the NMR structure ring I does not
ent binding sites of RNA aptamers specific for tobra- intercalate into the A site pocket; (2) ring I does not form
mycin [23, 24]. The positions of ring III and of the exocy- a pseudo base pair with A1408; (3) adenines A1492 and A1493
clic 6 and 6″ functional groups are changed due to the do not bulge out of the helix; and (4) conserved positions
different RNA environment surrounding the antibiotic, in the neamine moiety do not interact with the phosphate
but the direct intramolecular hydrogen bonds within the oxygens of the bulging adenines (Figure 5). Although
antibiotic are maintained. the pioneering NMR work [17, 19] correctly outlined the
As concluded from several biochemical experiments binding pocket of aminoglycosides in the A site, several
[14, 25–27] and theoretical approaches [28], a key driv- conserved contacts and RNA conformations were
ing force in the binding of aminoglycosides to RNA is of missed. The precise knowledge of the specific contacts
electrostatic origin; ammonium groups of the positively occurring in the binding pocket is a prerequisite not only
charged aminoglycoside displace cations normally at- for understanding the biological action of the antibiotic
tracted to the negatively charged RNA. However, the but also for the development of alternative compounds
acting in an analogous fashion.number of contacts seen in these two crystalline com-
Chemistry & Biology
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Table 2. Identical and Similar Contacts Formed by Hydrophilic Groups between the Aminoglycosides Tobramycin and Paromomycin
and the RNA
Tobramycin Paromomycin
Ammonium Groups (5) Ammonium Groups (5)
Direct Direct
N1...O4(U1495): 2.56 N1...O4(U1495): 2.82
N3...O1P(A1493): 3.05 N3...O1P(A1493): 3.13
N3...N7(G1494): 2.72 N3...N7(G1494): 2.78
N3...O2P(G1494): 2.55 N3...O2P(G1494): 3.12
N6...N1(A1408): 3.14 —
N3″...N7(G1405): 2.71 N2...O2P(G1405): 2.96
Water-mediated Water-mediated
N1...W...N4(C1496): 3.54/2.52 N1...W...W...N4(C1496): 2.68/2.71/2.51
N2...W...O2P(G1491): 2.90/3.48 N2...W...O2P(G1491): 3.47/3.24
N2...W...O1P(A1493): 3.04/3.12 N2...W...O1P(A1493): 3.27/2.89
N2...W...O2P(A1492): 2.90/3.00
Intramolecular Intramolecular
N1...O2: 2.98 N2...O5″: 3.12
N2...W...O5: 2.84/3.00 N2...O4″: 3.21
No contact to RNA No contact to RNA
None N6
Total to RNA: 10 Total to RNA: 8
Hydroxyl Groups (5) Hydroxyl Groups (8)
Direct Direct
— O3...O2P(A1492): 2.90
O4...O2P(A1493): 2.66 O4...O2P(A1493): 2.54
— O6...N1(A1408): 2.53




O5...W...W...N7(G1491): 3.00/3.43/2.53 O6...W...O4(U1495): 2.62/2.98
O6...W...O6(G1405): 3.21/3.19
Intramolecular Intramolecular
O5...O5″: 3.22 O5″...N2: 3.12




Total to RNA: 3 Total to RNA: 8
Ring Oxygen (2) Ring Oxygen (3)
Direct Direct
O5...N6(A1408): 2.93 O5...N6(A1408): 3.16
Intramolecular Intramolecular
O5″...O5: 3.22 O4″...N2: 3.21
Total to RNA: 1 Total to RNA: 1
Linkage Oxygen (2) Linkage Oxygen (3)
No contact No contact
Identical contacts are in bold; similar contacts are in bold italics. Distances are given in A˚.
Relations between the Structure of the Complex well as an A1491 instead of a G1491 and a reversed
A1410-U1490 base pair. Antibiotics belonging to the 4,6-and Bacterial Resistance
Resistance in bacteria can result from different mecha- linked subclass might therefore bind in a slightly differ-
ent manner to the eukaryotic A site in order to be activenisms, involving base mutations, base methylations, or
enzymatic modifications of the antibiotic [30]. The role despite the base changes.
Methylation of the N7 of G1405 confers resistance toof the A1408G mutation has already been emphasized
[21]. A guanine at position 1408 disfavors the binding of the 4,6-linked 2-deoxystreptamine aminoglycosides
such as tobramycin but not to the 4,5-linked aminogly-the aminoglycoside by presenting Watson-Crick groups
not able to form the necessary direct hydrogen bonds cosides such as paromomycin [32]. Indeed, whereas
ring III of tobramycin interacts directly with N7(G1405)with atoms O5 and N6 of ring I. Although the A1408G
mutation confers resistance to aminoglycosides in eu- (Figures 3A–3C), paromomycin does not reach directly
to that base [21]. The mutation U1406A has also beenbacteria [31], it does not prevent the binding of 4,6-
linked aminoglycosides to the eukaryotic A site [16], reported to prevent the binding of aminoglycosides be-
longing to the 4,6-linked subclass in a selective mannerwhich presents a G at the equivalent position 1408, as
Crystal Structure of the A Site Complexed to Tobramycin
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Figure 5. Superimposition of the Crystal
Structure of the Tobramycin/A Site Complex
and the NMR Structure of the Gentamicin
C1a/A Site Complex
(A) Stereo view down the deep groove of the A
site. The tobramycin/A site complex (present
work) and the gentamicin C1a/A site complex
(single representative structure from [19]) are
colored in blue and red shades, respectively.
The superimposition has been done with
atoms belonging to the neamine part in the
software Lsqman [46]. The adenines 1492
and 1493 are shown in bold for both com-
plexes.
(B) Stereo view of the A site at 180 from (A).
Residues A1408, A1492, A1493, and G1494 are shown
in bold for both complexes.
[33, 34]. In our previous structure containing paromomy- nucleotidyl group on position O4of several aminoglyco-
sides, has been solved by X-ray crystallography whilecin (a 4,5-linked aminoglycoside), a water molecule brid-
ges the hydroxyl group O6 of ring II to O4 of U1406. It can it was complexed to two kanamycin A molecules [36].
It is noteworthy that the three rings of this 4,6-disubsti-therefore be suspected that in the case of a U1406A
mutation, a direct hydrogen bond could form between tuted antibiotic, close in chemical structure to tobra-
mycin, keep the same chair conformations inside theO6 of ring II and N6 of A1406 for 4,5-linked aminoglyco-
sides. The involvement of O6 in the linkage with ring III modifying enzyme, whereas their orientations to one
another, possibly because of rotations around the etherin tobramycin (a 4,6-linked aminoglycoside) prevents
the formation of this water-mediated hydrogen bond to linkage, are different when compared to the conforma-
tion they adopt inside the A site pocket. It could beO4(U1406), and no other functional group of tobramycin
is in a proper orientation to interact with U1406. Thus, valuable to seek the antibiotic activity of a neamine
derivative having a closed ring between N2 of ring Iinstead of preventing a direct interaction between tobra-
mycin and the residue at position 1406, the mutation and O5 of ring II. Such a structure would prevent the
rotations of the rings around the ether linkages. TheseU1406A would more likely cause a steric clash between
N6(A1406) and ring III of tobramycin. Tobramycin and the modifications would also replace water-mediated intra-
molecular H bonds by covalent bonds and direct hydro-other 4,6-linked aminoglycosides are therefore probably
unable to accommodate the U1406A mutation. gen bonds.
Enzymatic modifications, such as adenylation and
acetylation, of the aminoglycosides are mainly aimed at
the neamine part functional groups (e.g., O4, N3, and Significance
N6) [8, 35] that are involved in critical H bonds between
the aminoglycoside and the RNA. It can be inferred from Small molecules binding to RNA targets have recently
the present crystal structure that adding chemical gained pharmaceutical interest [4, 37, 38]. Interaction
groups on these positions would prevent the formation of aminoglycoside antibiotics with the prokaryotic ri-
of conserved and specific hydrogen bonds between the bosomal A site is thought to be one of the sources of
antibiotic and its target. their bactericidal effect [8]. We have solved the struc-
ture of a complex formed by two tobramycin mole-
cules and a construct containing two A sites. To ourImplications for Drug Design
knowledge, this is the first X-ray crystal structureThe comparison of the paromomycin and tobramycin
showing the interaction of a clinically used 4,6-linkedcomplexes provides some insights for drug design. It
aminoglycoside with the A site. Beyond the under-would be indeed interesting to investigate the binding
standing of the molecular recognition and the specificof a molecule possessing both rings in positions 5 and
resistance patterns observed in compounds belonging6 of ring II, instead of only one. Such a strategy would
to this subclass, the analysis of the contacts and themaximize the number of direct H bonds to the RNA. In
comparison between this structure and the one solvedaddition, the structure of a dimeric kanamycin A nucleo-
tidyl transferase, which catalyzes the addition of any with a 4,5-linked aminoglycoside paromomycin [21]
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